DJ-1
MUL1
AKT1
leucine-rich repeat kinase-2
LRRK2 mutation
PD
PKBβ
ine kinasesOncogenic
AKT3
MLK family
serine/threonine kinase
apoptosis-inducing kinase 1
AP-1
c-Abl
serine/threonine protein kinase
moesin
FBP
mitogen-activated protein kinase
LRRK2LRRK2
Jun N-terminal kinase 3
apoptosis signal-regulating kinase 1Akt1
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
Parkinson’s disease kinase PINK1
LRRK2 GTP bindingKinase
G2019s LRRK2
GluR6-9c peptide
JNK3
far up stream element binding protein
protein POSH
c-Jun N-terminal kinase
PKBγ
c-Jun
c-Jun NH2-terminal kinase 3
ligase
BIM
Parkin E3 ligase
protein kinase B
DAT
c-Abl protein tyrosine kinase
LRRK2
mixed-lineage kinase
JNK
-rich repeat kinase 2
PKB
ERKs
JNK-interacting protein
SRC family
PINK1Exp
PINK1Hereditary
Bcr
Ha-Ras
STK39
AKT2
serine/threonine protein kinases
FAS ligand
PINK1 mutations
ubiquitin
tyrosine kinase
LRRK2 kinase
COX-2
PARK8
leucine-rich repeat kinase 2
TH
ASK1
PINK1
Abl family kinasesRegulation
Parkinson’s disease mutants affect
NF-κB
AIMP2
extracellular signal-related kinases
parkin
R1441C/G mutantsLRK-1
PI3K
erminal kinase
GTPase
Jun-N-terminal kinase
Serine 65PINK1
AKT
MAPK
rich repeat kinase 2
DA transporter
Akt
Rac1-binding scaffold protein
MPT
cyclooxygenase 2
c-Abl tyrosine-kinase
POSH
threonine and tyrosine kinases
phosphatase and tensin homolog
tyrosine kinases
mitochondrial cytochrome c
α-synuclein
pink1
kinase-AKT
PTEN
Abl
c-Jun activation domainCEP-1347
PKBα
apoptosis signal-regulating kinase 1
G2019S LRRK2 mutationThe
Nix
FAS ligand promoterDominant
p38 kinases
POSHPOSH
MEK kinase 1
activating protein-1
Parkin
